Literature DB >> 18248334

The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium.

C Matheï1, S Van Dooren, P Lemey, P Van Damme, F Buntinx, A-M Vandamme.   

Abstract

We employed recently developed statistical methods to explore the epidemic behaviour of hepatitis C subtype 1a and subtype 3a among injecting drug users (IDUs) in Flanders, Belgium, using new gene sequence data sampled among two geographically distinct populations of IDUs. First the extent of hepatitis C transmission across regions/countries was studied through calculation of association indices. It was shown that viral exchange had occurred between both populations in Flanders as well as across international borders. Furthermore, evidence was found suggestive of subtypes 1a and 3a predominantly circulating in subpopulations of Flemish IDUs, exhibiting different degrees of travelling/migration behaviour. Secondly, through coalescent-based analysis the viral epidemic history of the hepatitis C subtype 1a and 3a epidemics was inferred. Evidence was found for different dynamic forces driving both epidemics. Moreover, results suggested that the hepatitis C subtype 3a epidemic has reached a steady state, while the hepatitis C 1a epidemic has not, which therefore might become the predominant subtype among IDUs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248334     DOI: 10.1111/j.1365-2893.2007.00950.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

1.  Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.

Authors:  G V Matthews; S T Pham; M Hellard; J Grebely; L Zhang; A Oon; P Marks; I van Beek; W Rawlinson; J M Kaldor; A Lloyd; G J Dore; P A White
Journal:  Clin Infect Dis       Date:  2011-01-31       Impact factor: 9.079

2.  A time since onset of injection model for hepatitis C spread amongst injecting drug users.

Authors:  S Corson; D Greenhalgh; S J Hutchinson
Journal:  J Math Biol       Date:  2012-08-28       Impact factor: 2.259

3.  Social networks shape the transmission dynamics of hepatitis C virus.

Authors:  Camila Malta Romano; Isabel M V Guedes de Carvalho-Mello; Leda F Jamal; Fernando Lucas de Melo; Atila Iamarino; Marco Motoki; João Renato Rebello Pinho; Edward C Holmes; Paolo Marinho de Andrade Zanotto
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

4.  Molecular and spatial epidemiology of HCV among people who inject drugs in Boston, Massachusetts.

Authors:  Thomas J Stopka; Omar Yaghi; Min Li; Elijah Paintsil; Kenneth Chui; David Landy; Robert Heimer
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

5.  Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa.

Authors:  Richard Njouom; Mélanie Caron; Guillaume Besson; Guy-Roger Ndong-Atome; Maria Makuwa; Régis Pouillot; Dieudonné Nkoghé; Eric Leroy; Mirdad Kazanji
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

6.  Coalescent inference for infectious disease: meta-analysis of hepatitis C.

Authors:  Bethany Dearlove; Daniel J Wilson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237

7.  Prevalence of HCV among people who inject drugs in Brussels-a respondent-driven sampling survey.

Authors:  Luk Van Baelen; Els Plettinckx; Jérôme Antoine; Lies Gremeaux
Journal:  Harm Reduct J       Date:  2020-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.